← Back to catalogue

CONFIRM antiProgesterone Receptor PR 1E2 Rabbit Monoclonal Primary Antibody

FDA UDI

Class II (US FDA UDI)

by Ventana Medical Systems

Identity

Trade Name
CONFIRM antiProgesterone Receptor PR 1E2 Rabbit Monoclonal Primary Antibody FDA UDI
Generic Name
Progesterone receptor IVD, antibody FDA UDI
Model / Reference
50 tests FDA UDI

Identifiers

Catalog Number
05277990001 FDA UDI
Primary DI / UDI-DI
04015630972180 FDA UDI
FDA Product Code
MXZ FDA UDI
GMDN Term
Progesterone receptor IVD, antibody FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
864.1860 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Progesterone receptor IVD, antibody

CONFIRM antiProgesterone Receptor PR 1E2 Rabbit Monoclonal Primary Antibody by Ventana Medical Systems — Class II — FDA UDI — listed in FDA GUDID

Similar devices

Also classified as Progesterone receptor IVD, antibody.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI a32ee454-cd04-4377-ade7-3f725a4e30dd 33 fields · synced May 29, 2026